Serotonin transporter promoter polymorphism and dopaminergic sensitivity in alcoholics

被引:0
作者
Henning Budde
Thomas Sander
Catrin Wernicke
Anett Müller
Jürgen Gallinat
Lutz G. Schmidt
Michael N. Smolka
机构
[1] Humboldt University,Department of Movement and Training Science, Institute of Sport Science
[2] University of Cologne,Cologne Center for Genomics
[3] Charité University Medicine Berlin,Section of Clinical Neurobiology, Department of Psychiatry and Psychotherapy
[4] Technische Universität Dresden,Department of Psychology
[5] Charité University Medicine Berlin,Department of Psychiatry and Psychotherapy
[6] Universität Mainz,Department of Psychiatry and Psychotherapy
[7] Technische Universität Dresden,Section of Systems Neuroscience, Department of Psychiatry and Psychotherapy
来源
Journal of Neural Transmission | 2010年 / 117卷
关键词
Serotonin transporter; Dopamine; Alcohol; Apomorphine; Growth hormone;
D O I
暂无
中图分类号
学科分类号
摘要
The central serotonin (5-HT) system plays an important role in the rewarding and addictive properties of alcohol by a direct activation of the mesolimbic dopamine (DA) system. An insertion/deletion (L/S) promoter polymorphism (5-HTTLPR) of the 5-HT transporter (5-HHT) gene (SLC6A4) has been shown to influence transcriptional activity. It is predicted that reduced transynaptic 5-HT neurotransmission in alcoholics with the L/L genotype of 5-HTTLPR would result in a change in DA function compared to the S/S genotype. Thus the present study has tested whether dopaminergic sensitivity is influenced by the 5-HTTLPR genotype. Dopaminergic sensitivity, 5-HTTLPR genotype and smoking status were assessed in 121 alcoholics. Dopaminergic sensitivity as an indicator of the functional state of the dopaminergic system was measured by the amount of growth hormone (GH) secretion after subcutaneous administration of apomorphine (APO, 0.01 mg/kg). 5-HTTLPR genotype was significantly associated with dopaminergic sensitivity (P = 0.004) explaining 9.2% of the variance of GH response. Subjects homozygous for the L allele (with high 5-HTT expression) showed the lowest GH response, whereas those homozygous for the S allele (with low 5-HTT expression) showed the highest GH response (this was intermediate in heterozygous participants). Furthermore smoking was associated with a significantly reduced GH response (P = 0.006). Our findings indicate that the postsynaptic dopaminergic sensitivity is influenced by the 5-HTTLPR genotype. It is hypothesized that the reduction of sensitivity of the central DA receptors in alcoholics with the L/L genotype might be due to their higher vulnerability to the neurotoxic effects of chronic alcohol consumption than the S carriers.
引用
收藏
页码:133 / 138
页数:5
相关论文
共 50 条
  • [21] Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder
    Bengel, D
    Greenberg, BD
    Corá-Locatelli, G
    Altemus, M
    Heils, A
    Li, Q
    Murphy, DL
    MOLECULAR PSYCHIATRY, 1999, 4 (05) : 463 - 466
  • [22] Early family environment, current adversity, the serotonin transporter promoter polymorphism, and depressive symptomatology
    Taylor, Shelley E.
    Way, Baldwin M.
    Welch, William T.
    Hilmert, Clayton J.
    Lehman, Barbara J.
    Eisenberger, Naomi I.
    BIOLOGICAL PSYCHIATRY, 2006, 60 (07) : 671 - 676
  • [23] Association study of alcoholism subtypes with a functional promoter polymorphism in the serotonin transporter protein gene
    Kranzler, H
    Lappalainen, J
    Nellissery, M
    Gelernter, J
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2002, 26 (09) : 1330 - 1335
  • [24] Serotonin transporter promoter gene polymorphism and long-term outcome of antidepressant treatment
    Lee, MS
    Lee, HY
    Lee, HJ
    Ryu, SH
    PSYCHIATRIC GENETICS, 2004, 14 (02) : 111 - 115
  • [25] No association between non-violent suicidal behavior and the serotonin transporter promoter polymorphism
    Courtet, P
    Buresi, C
    Abbar, M
    Baud, P
    Boulenger, JP
    Castelnau, D
    Mouthon, D
    Malafosse, A
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2003, 116B (01) : 72 - 76
  • [26] Relationships between serotonin transporter promoter polymorphism, platelet serotonin transporter binding and clinical phenotype in suicidal and non-suicidal adolescent inpatients
    Zalsman, G
    Anderson, GM
    Peskin, M
    Frisch, A
    King, RA
    Vekslerchik, M
    Sommerfeld, E
    Michaelovsky, E
    Sher, L
    Weizman, A
    Apter, A
    JOURNAL OF NEURAL TRANSMISSION, 2005, 112 (02) : 309 - 315
  • [27] Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders
    Yu, YWY
    Tsai, SJ
    Chen, TJ
    Lin, CH
    Hong, CJ
    MOLECULAR PSYCHIATRY, 2002, 7 (10) : 1115 - 1119
  • [28] Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders
    Y W-Y Yu
    S-J Tsai
    T-J Chen
    C-H Lin
    C-J Hong
    Molecular Psychiatry, 2002, 7 : 1115 - 1119
  • [29] No association of a functional polymorphism in the serotonin transporter gene promoter and anxiety-related personality traits
    Lang, UE
    Bajbouj, M
    Wernicke, C
    Rommelspacher, H
    Danker-Hopfe, H
    Gallinat, J
    NEUROPSYCHOBIOLOGY, 2004, 49 (04) : 182 - 184
  • [30] An investigation of the relationship between serotonin transporter gene promoter polymorphism and psoriasis susceptibility in a Thai population
    Tencomnao, T.
    Wongpiyabovorn, J.
    GENETICS AND MOLECULAR RESEARCH, 2010, 9 (04): : 2275 - 2282